364.80CHF+1.33%Mkt Cap: 5.47B $P/E: 22.391d ago
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap5.47B $
Enterprise Value5.70B $
Revenue (TTM)834.27M $
Gross Profit359.06M $
Net Income (TTM)253.29M $
Revenue/Share61.31 USD
Last Price364.80 CHF
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990
Valuation
P/E (Trailing)22.39
P/E (Forward)24.04
PEG4.22
EV/EBITDA15.32
EV/Revenue6.83
P/S6.56
P/B6.17
EPS (TTM)16.29
EPS (Forward)15.18
52W Range
260.5058% of range441.50
52W High441.50 CHF
52W Low260.50 CHF
Profitability
Gross Margin43.04%
Oper. Margin26.45%
EBITDA Margin44.57%
Profit Margin30.36%
ROE29.66%
ROA16.48%
Growth
Revenue Growth-13.30%
Earnings Growth51.70%
Cash Flow & Leverage
Operating CF350.11M $
CapEx (TTM)368.76M $
FCF Margin-7.83%
FCF Yield-1.19%
Net Debt265.02M $
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity0.35
Current Ratio1.07
Quick Ratio0.73
Book Value/Sh59.15 CHF
Cash/Share2.172 CHF
Dividends
Fwd Div Rate4.400 CHF
Trail. Div Rate4.400 CHF
Div. Yield1.22%
5Y Avg Yield0.54%
Payout Ratio13.50%
Ex-Div DateJul 3, 2026
Pay DateJul 3, 2024
Analyst Consensus
Rating—
Target (Mean)387.83 CHF
Upside (mean)+6.3%
Target Range280.00 CHF – 440.00 CHF
CHF280.00+6.3% to meanCHF440.00
# Analysts12
Ownership
Shares Out.13.15M
Float3.51M
Insiders71.80%
Institutions15.39%
Technical
SMA 50321.70 (+13.4%)
SMA 200316.24 (+15.4%)
Beta0.78
S&P 52W Chg20.05%
Avg Vol (30d)20.31K
Avg Vol (10d)11.19K
Technical Indicators
RSI (14)66.9
MACD9.4191
MACD Signal9.8602
MACD Hist.-0.4411
BB Upper363.87 CHF
BB Middle350.29 CHF
BB Lower336.71 CHF
BB Width7.76%
ATR (14)9.747 CHF
Vol Ratio (20d)0.81x